Sign inJoin waitlistJoin the waitlist

Prashant Kapoor

Oncologist · Mayo Clinic College of Medicine and Science

Credentials: · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Hematology
2002–2003
Internal Medicine
1999–2002
Doctor of Medicine
1995–1999

Research

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
Leukemia · 2014 · 1,142 citations
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013
Mayo Clinic Proceedings · 2013 · 428 citations
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
Blood · 2017 · 269 citations

Morie Gertz
341 papers
Shaji Kumar
338 papers
Angela Dispenzieri
316 papers
Francis Buadi
305 papers
David Dingli
297 papers
ML
Martha Lacy
273 papers
Wilson Gonsalves
265 papers · 6 as a fellow
Suzanne Hayman
258 papers
Nelson Leung
255 papers
SR
Sundararajan Rajkumar
244 papers
Taxiarchis Kourelis
242 papers · 11 as a fellow
RK
Robert Kyle
226 papers

Clinical trials

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia
Principal investigator · Not yet recruiting · Phase 1, Phase 2
Mayo Clinic
2026–2038
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study
Principal investigator · Active not recruiting · Phase 1, Phase 2
Mayo Clinic
2022–2028
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial
Principal investigator · Active not recruiting · Phase 1, Phase 2
Mayo Clinic
2021–2027
Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma
Principal investigator · Completed · Phase 2
Mayo Clinic
2017–2021